Journey Medical (DERM) Finished Goods (2020 - 2021)
Journey Medical's (DERM) quarterly Finished Goods came in at $4.3 million in Q4 2021, up 205.56% on a YoY basis from $1.4 million in Q4 2020, and down 30.37% quarter-over-quarter from $6.2 million in Q3 2021.
Powered by 
Analysis
Journey Medical (DERM) Finished Goods (2020 - 2021) Analysis & Trends
Journey Medical (DERM) has reported Finished Goods for 2 consecutive years, with $4.3 million the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Finished Goods rose 205.56% year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2021 stood at $4.3 million (up 205.56% YoY), and the FY2021 full-year result was $4.3 million, up 205.56% from the prior year.
- Finished Goods eased to $4.3 million in Q4 2021 per DERM's latest filing, from $6.2 million in the prior quarter.
- Across five years, Finished Goods topped out at $6.2 million in Q3 2021 and bottomed at $1.4 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Journey Medical | 209.23 Mn | 183.58 Mn | 12.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 4.29 Mn |
| Sep 30, 2021 | 6.16 Mn |
| Dec 31, 2020 | 1.40 Mn |